INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 449m ago
HOUSE PTR49m ago
SEC 13F49m ago
ROBINHOOD CHAIN48m ago
HOUSE PTR/SaleVerified data

Thomas H. Kean, Jr. sold BDX

Self · BECTON DICKINSON & CO · Becton, Dickinson and Company Common Stock

Side
SELL
Value range
$1,001 – $15K
Shares
Not disclosed
Price
—
Executed
May 21, 2026
Disclosed
Jun 18, 2026
Disclosure timeline28 days from execution to publication · legal deadline 45 days
May 21 executedJun 18, 2026 disclosed

BDX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
20/ 100 · ROUTINE
Methodology →
  • Transaction type+10 / 20

    Sale

  • Relative size+2 / 25

    Disclosed range starting at $1K

  • Filing timing0 / 15

    Disclosed 28 days after execution (STOCK Act deadline: 45)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BDX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    1
    FM
    Feld MichaelEVP, Chief Revenue Officer
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$15K
    76 sh
    		Oct 26, 2026Oct 27, 2026
    traded Oct 26, 2026
    		+1dSEC FORM 4

    Evidence

    1
    FM
    Feld MichaelEVP, Chief Revenue Officer
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$14K
    76 sh
    		Sep 28, 2026Sep 29, 2026
    traded Sep 28, 2026
    		+1dSEC FORM 4

    Evidence

    5
    FM
    Feld MichaelEVP, Chief Revenue Officer
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$11K
    75 sh
    		Jun 26, 2026Jun 26, 2026
    traded Jun 26, 2026
    		+0dSEC FORM 4

    Evidence

    24
    Kevin HernRJoint
    BDXBECTON DICKINSON & CO
    Sale
    		SELL$15K – $50KMar 17, 2026Apr 3, 2026
    traded Mar 17, 2026
    		+17dHOUSE PTR

    Evidence

    9
    SL
    Spikner Pamela L.SVP Controller & CAO
    BDXBECTON DICKINSON & CO
    Tax withholding
    		F—
    84 sh
    		Jan 21, 2026Jan 23, 2026
    traded Jan 21, 2026
    		+2dSEC FORM 4

    Evidence

    12
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$209K
    1,010 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    13
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Disposition to issuer · 10b5-1 plan
    		D$513K
    2,454 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    13
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Option exercise · 10b5-1 plan
    		M$513K
    3,054 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    0
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Option exercise · 10b5-1 plan
    		M—
    3,054 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    8
    GD
    Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
    BDXBECTON DICKINSON & CO
    Open-market sale · 10b5-1 plan
    		SELL$125K
    600 sh
    		Jan 15, 2026Jan 16, 2026
    traded Jan 15, 2026
    		+1dSEC FORM 4

    Evidence

    9
    SD
    Shan DavidEVP and Chief ISC Officer
    BDXBECTON DICKINSON & CO
    Tax withholding
    		F—
    44 sh
    		Jan 3, 2026Jan 6, 2026
    traded Jan 3, 2026
    		+3dSEC FORM 4

    Evidence

    21
    SL
    Scott Bertram LDirector
    BDXBECTON DICKINSON & CO
    Open-market sale
    		SELL$38K
    217 sh
    		Nov 7, 2025Nov 7, 2025
    traded Nov 7, 2025
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    House Periodic Transaction Report
    Publisher
    Clerk of the U.S. House of Representatives
    Document ID
    20034783

    Timestamps

    Event (reported)
    May 21, 2026
    Published
    Jun 18, 2026
    Ingested by INSIDER
    Nov 5, 00:34 UTC
    Last re-read
    Nov 5, 06:47 UTC

    Extracted facts

    Filer
    Thomas H. Kean, Jr.
    Role
    Self
    Transaction
    SaleAs filed: “S”
    Asset
    Becton, Dickinson and Company Common Stock
    Ticker
    BDX
    Reported value
    $1,001 – $15KAs filed: “$1,001 - $15,000”
    Execution date (reported)
    May 21, 2026
    Notification date (reported)
    Jun 2, 2026
    Days from execution to publication
    28

    Calculation

    Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.

    • Low: $1,001
    • High: $15,000

    = $8,001

    What this establishes

    Thomas H. Kean, Jr. reported a sale of Becton, Dickinson and Company Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.

    Extraction

    Method
    PDF text extraction
    Confidence
    1.00
    Self
    Thomas H. Kean, Jr.bioguide:K000398
    Issuer
    BECTON DICKINSON & COcik:0000010795

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.